Arovella Therapeutics Ltd News

Arovella Therapeutics Ltd: AusBioInvest Presentation

Oct 28 17:37 ET

Arovella Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Oct 28 17:11 ET

Arovella Therapeutics Ltd: Arovella receives R&D tax rebate of $3.0 million

Oct 24 19:55 ET

Arovella Therapeutics Ltd: Notice Under Section 708A

Oct 23 17:37 ET

Arovella Therapeutics Ltd: Application for quotation of securities - ALA

Oct 23 17:21 ET

Arovella Therapeutics Ltd: Notice Under Section 708A

Oct 17 19:15 ET

Arovella Therapeutics Ltd: Application for quotation of securities - ALA

Oct 17 19:13 ET

Arovella Therapeutics Ltd: Notice Under Section 708A

Oct 16 01:40 ET

Arovella Therapeutics Ltd: Application for quotation of securities - ALA

Oct 16 01:36 ET

Arovella Therapeutics Ltd: Investor Presentation

Oct 15 17:23 ET

Arovella Therapeutics Ltd: Clinical Advisory Board established

Oct 13 18:47 ET

Arovella Therapeutics Ltd: Notice of Annual General Meeting/Proxy Form

Oct 8 20:05 ET

Arovella Therapeutics Ltd: Notification regarding unquoted securities - ALA

Oct 7 00:26 ET

Arovella Therapeutics Ltd: Release of Shares from Escrow

Sep 30 22:56 ET

Arovella Therapeutics Ltd: Notification regarding unquoted securities - ALA

Sep 18 19:54 ET

Arovella Therapeutics Ltd: Application for quotation of securities - ALA

Sep 18 19:51 ET

Arovella Therapeutics Ltd: Investor Webinar Presentation

Sep 17 20:30 ET

Arovella Therapeutics Ltd: Becoming a substantial holder

Sep 17 19:09 ET

Arovella Therapeutics Ltd: Change in substantial holding

Sep 17 19:05 ET

Arovella Therapeutics Ltd: Updated Investor Webinar Presentation

Sep 12 03:18 ET